| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |